1. Activation of (un)regulated cell death as a new perspective for bispyridinium and imidazolium oximes
   Antonio Zandona et al, 2021, Archives of Toxicology CrossRef
2. Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
   Abderrahim El Guerrab et al, 2016, Oncotarget CrossRef
3. Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the acquired resistance of AZD9291 in H1975 cells
   Zhongwei Liu et al, 2020, Archives of Toxicology CrossRef
4. Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
   Manzar Alam et al, 2022, Frontiers in Oncology CrossRef
5. AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations
   Ren Zhao et al, 2016, BMC Cancer CrossRef
6. Vorinostat and metformin sensitize EGFR-TKI resistant NSCLC cells via BIM-dependent apoptosis induction
   Hengyi Chen et al, 2017, Oncotarget CrossRef
7. Lentivirus-mediated silencing of HOTAIR lncRNA restores gefitinib sensitivity by activating Bax/Caspase-3 and suppressing TGF-α/EGFR signaling in lung adenocarcinoma
   Yuanshun Liu et al, 2017, Oncology Letters CrossRef
8. Biological response and cell death signaling pathways modulated by tetrahydroisoquinoline-based aldoximes in human cells
   Antonio Zandona et al, 2023, Toxicology CrossRef
9. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer
   G Sette et al, 2015, Cell Death & Disease CrossRef
10. Design, synthesis, and molecular modeling of quinoline‐based derivatives as anti‐breast cancer agents targeting EGFR/AKT signaling pathway
    Rasha Z. Batran et al, 2022, Chemical Biology & Drug Design CrossRef
11. Enantiomeric Polyketides from the Starfish‐Derived Symbiotic Fungus Penicillium sp. GGF16‐1‐2
    Xia Wei et al, 2019, Chemistry & Biodiversity CrossRef
12. MiR‐326 regulates the proliferation and apoptosis of endometrial cancer by targeting Bcl‐2
    Lily Cai et al, 2021, Journal of Obstetrics and Gynaecology Research CrossRef
13. Malayoside, a cardenolide glycoside extracted from Antiaris toxicaria Lesch, induces apoptosis in human non-small lung cancer cells via MAPK-Nur77 signaling pathway
    Qiong-Ying Hu et al, 2021, Biochemical Pharmacology CrossRef
14. SPOC: Identification of Drug Targets in Biological Networks via Set Preference Output Control
    Hao Gao et al, 2020, Bioinformatics Research and Applications CrossRef
15. Gefitinib induces non‑small cell lung cancer H1650 cell apoptosis through downregulating tumor necrosis factor‑related apoptosis‑inducing ligand expression levels
    Hanjie Yi et al, 2018, Oncology Letters CrossRef
16. Advances in research on the effects of platelet activation in acute lung injury (Review)
    Yuan Xin et al, 2022, Biomedical Reports CrossRef
17. Organotypic three-dimensional cancer cell cultures mirror drug responsesin vivo: lessons learned from the inhibition of EGFR signaling
    Nico Jacobi et al, 2017, Oncotarget CrossRef
18. Bcl-2 and Bcl-xL mediate resistance to receptor tyrosine kinase-targeted therapy in lung and gastric cancer
    Junfei Jin et al, 2017, Anti-Cancer Drugs CrossRef
19. New Indole Diketopiperazine Alkaloids from Soft Coral‐Associated Epiphytic Fungus Aspergillus sp. EGF 15‐0‐3
    Xia Wei et al, 2020, Chemistry & Biodiversity CrossRef
20. A review on RNAi therapy for NSCLC: Opportunities and challenges
    Vignesh Kumar et al, 2021, WIREs Nanomedicine and Nanobiotechnology CrossRef
21. New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents
    Rania Hamdy et al, 2021, International Journal of Molecular Sciences CrossRef